secwatch.observer — SEC 8-K summary
======================================

Issuer:     KYNTRA BIO, INC. (KYNB)
CIK:        0000921299
Form:       8-K
Filed at:   2024-09-13T23:59:59+00:00
Accession:  0000950170-24-106359
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

FibroGen directors Blaug, Cravatt, Lema resign effective Sept 30; committees reassigned
--------------------------------------------------------------------------------

- Suzanne Blaug, Benjamin Cravatt, and Gerald Lema resign from the Board effective September 30, 2024.
- Resignations are not due to any disagreement with the Company or its management.
- Audit Committee now comprises Jeffrey L. Edwards (Chair), Maykin Ho, and James A. Schoeneck.
- Compensation Committee: James A. Schoeneck (Chair) and Aoife Brennan; Nominating Committee: James A. Schoeneck (Chair) and Jeffrey L. Edwards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/921299/000095017024106359/0000950170-24-106359-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/921299/000095017024106359/fgen-20240912.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-106359

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer